Sector: Pharmaceuticals & Biotechnology

Small Cap

Coral Laboratories Share Price

CORALAB

₹577.90

21.75(3.91%)

28th Jul 2026 | 9:20 AM

NSE :

Open Free Demat Account

Coral Laboratories Performance

Price Movement

N/A

₹556.15

₹579.90

↘ Today's Low↗ Today's High

1 Year Performance

Data is not available

Markets Today

High₹579.90

Low₹556.15

Open at₹556.15

Prev Close₹556.15

Volumes12

Avg Price₹573.69

Lower Circuit₹528.35

Upper Circuit₹583.95

Historical Performance

3M High₹659.00

3M Low₹405.70

1 Yr High₹659.00

1 Yr Low₹360.00

3 Yr High₹999.00

3 Yr Low₹245.00

5 Yr High₹999.00

5 Yr Low₹217.00

Summary

As of 28-07-2026 11:15, Coral Laboratories Ltd. share price today is ₹0, with a change of ₹-556.15 (-100.00%) from the previous close of ₹556.15. The stock opened at ₹556.15 and traded between ₹556.15 and ₹579.9, with a total traded volume of 12 shares. The company has a market capitalization of ₹207.9 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹659 and ₹360, respectively.

Coral Laboratories Ltd. valuation metrics include a P/E ratio of 12.7, and book value of ₹1.00. Profitability indicators show ROE of 7.83% along with a dividend yield of 0.3%. Coral Laboratories Ltd. has reported revenue of ₹85.9 Cr and net profit of ₹16.38 Cr.

Coral Laboratories Ltd. technical indicators include Day RSI at 51.26, Day MFI at 44.76, Day ADX at 17.72. Additional indicators include Commodity Channel Index (CCI) at -151.4 and Williams %R at -63.42. Momentum indicators show Day MACD at 9.15, Day MACD Signal Line at 16.63, DayATR at 26.26. Rate of Change indicators for Coral Laboratories Ltd. include ROC125 at 32.5 and ROC21 at -10.17.

Exponential moving averages include EMA5 at ₹582.8, EMA10 at ₹588, EMA12 at ₹588.8, EMA20 at ₹585.7, EMA26 at ₹579.6, EMA50 at ₹550.4, EMA100 at ₹515.1, EMA200 at ₹509.5. Simple moving averages include SMA5 at ₹583.8, SMA10 at ₹592.4, SMA20 at ₹598.4, SMA30 at ₹585, SMA50 at ₹544.4, SMA100 at ₹482.3, SMA150 at ₹471.3, SMA200 at ₹477.3.

Support levels for Coral Laboratories are placed at First Support ₹567.30, Second Support ₹552.65, Third Support ₹545.30. Resistance levels are seen at First Resistance ₹589.30, Second Resistance ₹596.65, Third Resistance ₹611.30. Coral Laboratories Ltd. shareholding pattern shows promoter holding at 71.51%, FII holding at 0%, DII holding at 0%, public holding at 28.49%.

Coral Laboratories Fundamentals

Market Cap

Below industry Median

207.90 Cr.

PE Ratio (TTM)

Below industry Median

12.70

Dividend Yield

Below industry Median

0.30

Net Profit TTM

32% decr over last year

16.38

Net Profit Growth

32% decr over last year

16.38

PEG Ratio

Negative PEG TTM

-0.40

ROE

35% decr over last year

7.83

Operating Revenue TTM

85.90

Operating Revenue Growth

25% decr over last year

Book Value

Low in industry

MFI

MFI is mid-range

44.76

RSI

RSI is mid-range

51.26

EPS (TTM)

Debt to Equity

Face Value

Operating Profit Margin Qtr.

Operating Profit Qtr.

Net Profit Qtr.

Operating Revenue Qtr.

PB Ratio

Coral Laboratories Financials

*All values are in Rs. Cr

Loading chart...

Indicator	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Total Revenue	26.48	21.56	19.03	18.82	28.13
Operating Expense	20.28	19.67	14.10	16.64	25.45
Operating Profit	6.20	1.89	4.94	2.18	2.68
Depreciation	0.54	0.69	0.45	0.45	0.51
Interest	0.01	0	0.10	0.06	0.04
Tax	3.06	0.92	1.60	1.16	1.02
Net Profit	5.22	2.78	5.82	2.56	2.83

Coral Laboratories Technicals

Coral Laboratories Ltd. EMA & SMA

₹577.90

8.90 (1.56%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹582.8

Day EMA10 ₹588

Day EMA12 ₹588.8

Day EMA20 ₹585.7

Day EMA26 ₹579.6

Day EMA50 ₹550.4

Day EMA100 ₹515.1

Day EMA200 ₹509.5

Coral Laboratories Support and Resistance

Resistance

First Resistance₹589.30

Second Resistance₹596.65

Third Resistance₹611.30

Support

First Support₹567.30

Second Support₹552.65

Third Support₹545.30

Technical Indicators

Day RSI51.26

Day MFI44.76

Day ADX17.72

Day Commodity Channel Index-151.40

William-63.42

Day MACD9.15

Day MACD Signal Line16.63

Day ATR26.26

Day ROC12532.50

Day ROC21-10.17

Coral Laboratories Shareholding Pattern

Held By	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Promoter	71.5	71.5	71.5	71.5	71.5	71.5
FII	0	0	0	0	0	0
DII	0	0	0	0	0	0
Public	28.5	28.5	28.5	28.5	28.5	28.5

Coral Laboratories Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	330	330	100.00%
Week	446	446	100.00%
1 Month	660	713	92.64%
6 Month	1.66 K	1.96 K	85.01%

Coral Laboratories SWOT Analysis

Strengths13

Weakness3

Opportunity0

Threats0

30 Day SMA crossing over 200 Day SMA, and current price greater than open

Companies with 10% increase in share price over three months, with rising net profit growth

Turnaround Potential (DVM)

PEG lower than Industry PEG

High Momentum Scores (Technical Scores greater than 50)

Growth in Net Profit with increasing Profit Margin (QoQ)

Companies with Low Debt

Increasing Revenue every quarter for the past 3 quarters

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Book Value per share Improving for last 2 years

Companies with Zero Promoter Pledge

Top Gainers

Stocks Outperforming their Industry Price Change in the Quarter

Coral Laboratories Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
19 Sep, 2025	1.5	FINAL	19 Sep, 2025	Equity Share
20 Sep, 2024	2	FINAL		Equity Share
19 Sep, 2019	2	FINAL		Equity Share
18 Sep, 2018	2	FINAL		Equity Share
11 Sep, 2017	5	FINAL		Equity Share
16 Sep, 2016	3	FINAL		Equity Share
08 Sep, 2015	2.5	FINAL		Equity Share
16 Sep, 2014	2	FINAL		Equity Share
18 Sep, 2013	1.5	FINAL		Equity Share
17 Sep, 2012	1.5	FINAL		Equity Share

Coral Laboratories Stock Comparison

Financials	Bio Medica Laboratories Ltd.	Goldline Pharmaceutical Ltd.	Sai Parenterals Ltd.	Speciality Medicines Ltd.	Accretion Nutraveda Ltd.	Rekvina Laboratories Ltd.
Price (₹)	₹141.55	₹38.37	₹550.90	₹180.05	₹284	₹25.27
% Change	0.07%	0.00%	-1.58%	0.00%	0.00%	-0.12%
Revenue TTM (₹ Cr)	-	-	-	-	-	₹1.27
Net Profit TTM (₹ Cr)	-	-	-	-	-	₹-0.25
PE TTM	66.30	8.90	-	12.50	39.10	-59.80
1 Year Return	-0.22		36.63			461.56
ROCE	-	-	3.56	-	-	-

Similar Stocks

VIVIMEDLAB

Vivimed Labs Ltd.

₹ 5.20

-1.14%

CURIS

Curis Lifesciences Ltd.

₹ 111.80

-0.18%

APPL

Aptus Pharma Ltd.

₹ 246.00

-1.80%

AMANTA

Amanta Healthcare Ltd.

₹ 160.00

+0.00%

AHCL

Anlon Healthcare Ltd.

₹ 15.57

-1.14%

MEDISTEP

Medistep Healthcare Ltd.

₹ 18.50

+0.00%

PATELCHEM

Patel Chem Specialities Ltd.

₹ 92.00

+0.88%

APL

Asston Pharmaceuticals Ltd.

₹ 62.00

-0.72%

INFLUX

Influx Healthtech Ltd.

₹ 285.00

+0.00%

MEDIORG

Medicamen Organics Ltd.

₹ 25.50

+0.00%

AMRUTANJAN

Amrutanjan Health Care Ltd.

₹ 514.65

+0.25%

ASTONEALAB

Astonea Labs Ltd.

₹ 271.00

+0.00%

AMWILL

Amwill Health Care Ltd.

₹ 39.60

-1.02%

VALIANTLAB

Valiant Laboratories Ltd.

₹ 60.10

-2.29%

SHELTER

Shelter Pharma Ltd.

₹ 26.80

-1.00%

TLL

Trident Lifeline Ltd.

₹ 263.55

+0.53%

DPL

Dipna Pharmachem Ltd.

₹ 4.49

+4.18%

ACHYUT

Achyut Healthcare Ltd.

₹ 6.94

+2.97%

SIGACHI

Sigachi Industries Ltd.

₹ 25.43

-1.97%

WINDLAS

Windlas Biotech Ltd.

₹ 853.55

-0.46%

VINEETLAB

Vineet Laboratories Ltd.

₹ 39.25

+0.98%

CBPL

Chandra Bhagat Pharma Ltd.

₹ 35.28

+5.00%

SOLARA

Solara Active Pharma Sciences Ltd.

₹ 502.80

-0.44%

FAQ's on CORALAB

What is the Market Capitalization of Coral Laboratories Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Coral Laboratories Ltd. is approximately ₹ 207.9 Cr.

What are the PE and PB ratios for Coral Laboratories Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Coral Laboratories Ltd. is 12.7, and the Price-to-Book (PB) ratio is 1.

What is the 52-Week High and Low for Coral Laboratories Ltd.?

Over the past 52 weeks, the highest price reached by Coral Laboratories Ltd. shares was ₹ 659, and the lowest price was ₹ 360.

What is the current dividend yield for Coral Laboratories Ltd.?

As of 6 June 2025, the dividend yield for Coral Laboratories Ltd. is 0.3%. The dividend yield is calculated based on the company's annual dividend payouts relative to its current share price.

Who are the major shareholders of Coral Laboratories Ltd.?

Significant shareholdings in Coral Laboratories Ltd. typically include entities such as:

Promoter
Public
Other Institutions

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Coral Laboratories Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Coral Laboratories Ltd. is often compared with other major players such as Bio Medica Laboratories, Goldline Pharmaceutical, Sai Parenterals, Speciality Medicines, Accretion Nutraveda and Rekvina Laboratories for analysis and benchmarking.

What is the latest dividend information for Coral Laboratories Ltd.?

Coral Laboratories Ltd. last declared a FINAL dividend of ₹ 1.5 per share for the financial period ending 2025. The record date was set as 2025-09-19, and the payment was/is scheduled around 2025-09-19. For the most current dividend announcements, refer to official company filings.

Invest Anytime, Anywhere

By signing up I certify terms, conditions & privacy policy